CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,014,043 | +210.0% | 543,586 | +243.3% | 0.00% | +200.0% |
| Q2 2023 | $5,165,605 | -36.9% | 158,357 | -32.0% | 0.00% | 0.0% |
| Q1 2023 | $8,189,206 | -1.6% | 232,714 | +28.1% | 0.00% | -50.0% |
| Q4 2022 | $8,321,370 | -15.6% | 181,610 | -10.7% | 0.00% | -33.3% |
| Q3 2022 | $9,854,000 | +69.1% | 203,371 | +37.2% | 0.00% | +200.0% |
| Q2 2022 | $5,826,000 | -4.1% | 148,281 | -10.2% | 0.00% | 0.0% |
| Q1 2022 | $6,078,000 | -69.7% | 165,108 | -62.5% | 0.00% | – |
| Q4 2021 | $20,088,000 | +193.9% | 440,720 | +130.5% | 0.00% | -100.0% |
| Q3 2021 | $6,834,000 | +6.3% | 191,219 | -41.1% | 0.00% | – |
| Q2 2021 | $6,429,000 | +76.9% | 324,827 | +107.8% | 0.00% | – |
| Q1 2021 | $3,635,000 | -57.9% | 156,287 | -62.4% | 0.00% | – |
| Q4 2020 | $8,642,000 | -59.7% | 415,942 | -58.0% | 0.00% | -100.0% |
| Q3 2020 | $21,418,000 | +304.6% | 989,283 | +340.5% | 0.00% | – |
| Q2 2020 | $5,293,000 | +74.9% | 224,568 | -12.5% | 0.00% | -100.0% |
| Q1 2020 | $3,026,000 | -13.4% | 256,714 | -22.0% | 0.00% | – |
| Q4 2019 | $3,494,000 | +32.2% | 329,288 | +41.8% | 0.00% | -100.0% |
| Q3 2019 | $2,643,000 | -64.7% | 232,270 | -65.1% | 0.00% | 0.0% |
| Q2 2019 | $7,485,000 | +1418.3% | 665,358 | +990.8% | 0.00% | – |
| Q1 2019 | $493,000 | -48.0% | 61,000 | -59.3% | 0.00% | – |
| Q4 2018 | $948,000 | +79.9% | 149,980 | +180.3% | 0.00% | – |
| Q3 2018 | $527,000 | -21.9% | 53,500 | -34.3% | 0.00% | – |
| Q2 2018 | $675,000 | -30.8% | 81,386 | -39.9% | 0.00% | – |
| Q1 2018 | $976,000 | -24.0% | 135,500 | -14.1% | 0.00% | – |
| Q4 2017 | $1,285,000 | -53.5% | 157,700 | -17.3% | 0.00% | -100.0% |
| Q3 2017 | $2,766,000 | +30.2% | 190,700 | +8.7% | 0.00% | 0.0% |
| Q2 2017 | $2,124,000 | +59.6% | 175,500 | +69.3% | 0.00% | – |
| Q1 2017 | $1,331,000 | +50.4% | 103,635 | +42.3% | 0.00% | – |
| Q4 2016 | $885,000 | -4.8% | 72,837 | -28.1% | 0.00% | – |
| Q3 2016 | $930,000 | +2.6% | 101,256 | +6.1% | 0.00% | – |
| Q2 2016 | $906,000 | -53.6% | 95,400 | -65.6% | 0.00% | -100.0% |
| Q1 2016 | $1,954,000 | +18.0% | 277,060 | +75.0% | 0.00% | 0.0% |
| Q4 2015 | $1,656,000 | +154.8% | 158,300 | +63.0% | 0.00% | – |
| Q3 2015 | $650,000 | -18.4% | 97,119 | -18.1% | 0.00% | – |
| Q2 2015 | $797,000 | +60.7% | 118,564 | +62.0% | 0.00% | – |
| Q1 2015 | $496,000 | -36.9% | 73,200 | -25.3% | 0.00% | – |
| Q4 2014 | $786,000 | +15.9% | 98,051 | -49.0% | 0.00% | – |
| Q3 2014 | $678,000 | -74.5% | 192,361 | -65.4% | 0.00% | – |
| Q2 2014 | $2,660,000 | -61.6% | 556,552 | -23.7% | 0.00% | -100.0% |
| Q1 2014 | $6,930,000 | +385.3% | 729,458 | +232.1% | 0.00% | – |
| Q4 2013 | $1,428,000 | -16.4% | 219,647 | -2.4% | 0.00% | -100.0% |
| Q3 2013 | $1,708,000 | – | 225,092 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |